(Q35165723)

6 August 2017

1 reference

title

Receptor targeting of adeno-associated virus vectors (English)

1 reference

6 August 2017

0 references

Büning H

1

1 reference

6 August 2017

Ried MU

2

1 reference

6 August 2017

Perabo L

3

1 reference

6 August 2017

Gerner FM

4

1 reference

6 August 2017

Huttner NA

5

1 reference

6 August 2017

Enssle J

6

1 reference

6 August 2017

Hallek M

7

1 reference

6 August 2017

publication date

1 July 2003

1 reference

6 August 2017

1 reference

6 August 2017

volume

10

1 reference

6 August 2017

issue

14

1 reference

6 August 2017

page(s)

1142-1151

1 reference

Epidemiology of adenovirus-associated virus infection in a nursery population

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301976

A seroepidemiologic study of adenovirus-associated virus infection in infants and children

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301976

The adeno-associated virus Rep78 gene inhibits cellular transformation induced by bovine papillomavirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301976

Inhibition of Cellular transformation by the adeno-associated virus rep gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301976

Site-specific integration by adeno-associated virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301976

Adeno-associated virus vectors for gene therapy: more pros than cons?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301976

Building a better vector: the manipulation of AAV virions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301976

Adeno-associated viruses having nonsense mutations in the capsid genes: Growth in mammalian cells containing an inducible amber suppressor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301976

AlphaVbeta5 integrin: a co-receptor for adeno-associated virus type 2 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301976

Purification of recombinant adeno-associated virus by iodixanol gradient ultracentrifugation allows rapid and reproducible preparation of vector stocks for gene transfer in the nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301976

Genetic capsid modifications allow efficient re-targeting of adeno-associated virus type 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301976

Progress in adeno-associated virus type 2 vector production: promises and prospects for clinical use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301976

New developments in the generation of Ad-free, high-titer rAAV gene therapy vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301976

High-efficiency transfer of the T cell co-stimulatory molecule B7-2 to lymphoid cells using high-titer recombinant adeno-associated virus vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301976

Viral receptors and vector purification: new approaches for generating clinical-grade reagents

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301976

Recombinant adeno-associated virus purification using novel methods improves infectious titer and yield

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301976

The atomic structure of adeno-associated virus (AAV-2), a vector for human gene therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301976

Electron cryo-microscopy and image reconstruction of adeno-associated virus type 2 empty capsids

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301976

The three-dimensional structure of canine parvovirus and its functional implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301976

Structure determination of feline panleukopenia virus empty particles

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301976

Functional implications of the structure of the murine parvovirus, minute virus of mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301976

The structure of human parvovirus B19 at 8 A resolution

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301976

Mutational analysis of the adeno-associated virus type 2 (AAV2) capsid gene and construction of AAV2 vectors with altered tropism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301976

Insertional mutagenesis of AAV2 capsid and the production of recombinant virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301976

Infectious entry pathway of adeno-associated virus and adeno-associated virus vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301976

Endocytosis and nuclear trafficking of adeno-associated virus type 2 are controlled by rac1 and phosphatidylinositol-3 kinase activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301976

GTPase activity of dynamin and resulting conformation change are essential for endocytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301976

Dynamin:GTP controls the formation of constricted coated pits, the rate limiting step in clathrin-mediated endocytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301976

Intracellular trafficking of adeno-associated virus vectors: routing to the late endosomal compartment and proteasome degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301976

Virus entry into animal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301976

The VP1 capsid protein of adeno-associated virus type 2 is carrying a phospholipase A2 domain required for virus infectivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301976

A viral phospholipase A2 is required for parvovirus infectivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301976

Real-time single-molecule imaging of the infection pathway of an adeno-associated virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301976

Cloning of adeno-associated virus into pBR322: rescue of intact virus from the recombinant plasmid in human cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301976

Nucleotide sequencing and generation of an infectious clone of adeno-associated virus 3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301976

Hybrid vectors based on adeno-associated virus serotypes 2 and 5 for muscle-directed gene transfer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301976

Repeat transduction in the mouse lung by using adeno-associated virus vectors with different serotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301976

Adeno-associated virus serotype 4 (AAV4) and AAV5 both require sialic acid binding for hemagglutination and efficient transduction but differ in sialic acid linkage specificity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301976

Cross-packaging of a single adeno-associated virus (AAV) type 2 vector genome into multiple AAV serotypes enables transduction with broad specificity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301976

Adeno-associated virus (AAV)-3-based vectors transduce haematopoietic cells not susceptible to transduction with AAV-2-based vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301976

Adeno-associated virus type 5 (AAV5) but not AAV2 binds to the apical surfaces of airway epithelia and facilitates gene transfer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301976

Adeno-associated virus type 6 (AAV6) vectors mediate efficient transduction of airway epithelial cells in mouse lungs compared to that of AAV2 vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301976

Recombinant adeno-associated virus type 2, 4, and 5 vectors: transduction of variant cell types and regions in the mammalian central nervous system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301976

Cell-surface receptors for retroviruses and implications for gene transfer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301976

Incorporation of tumor-targeting peptides into recombinant adeno-associated virus capsids

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301976

Insertional mutagenesis of the adeno-associated virus type 2 (AAV2) capsid gene and generation of AAV2 vectors targeted to alternative cell-surface receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301976

Development of novel cell surface CD34-targeted recombinant adenoassociated virus vectors for gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301976

Targeted adeno-associated virus vector transduction of nonpermissive cells mediated by a bispecific F(ab'gamma)2 antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301976

Efficient and selective AAV2-mediated gene transfer directed to human vascular endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301976

Adeno-associated virus capsids displaying immunoglobulin-binding domains permit antibody-mediated vector retargeting to specific cell surface receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301976

Structure, sequence, and function correlations among parvoviruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301976

Assaying for structural variation in the parvovirus capsid and its role in infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301976

Integrins as virus receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301976

Titration of AAV-2 particles via a novel capsid ELISA: packaging of genomes can limit production of recombinant AAV-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301976

Cell-specific targeting of Sindbis virus vectors displaying IgG-binding domains of protein A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301976

Targeted integration of adeno-associated virus (AAV) into human chromosome 19

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301976

7 January 2021

Adeno-associated virus Rep78 protein and terminal repeats enhance integration of DNA sequences into the cellular genome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301976

7 January 2021

Genetics of adeno-associated virus: isolation and preliminary characterization of adeno-associated virus type 2 mutants

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301976

7 January 2021

Subcellular compartmentalization of adeno-associated virus type 2 assembly

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301976

7 January 2021

Nuclear transport of the major capsid protein is essential for adeno-associated virus capsid formation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301976

7 January 2021

Genetic capsid modifications allow efficient re-targeting of adeno-associated virus type 2.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301976

7 January 2021

Membrane-associated heparan sulfate proteoglycan is a receptor for adeno-associated virus type 2 virions

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301976

7 January 2021

Human fibroblast growth factor receptor 1 is a co-receptor for infection by adeno-associated virus 2.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301976

7 January 2021

Infectious clones and vectors derived from adeno-associated virus (AAV) serotypes other than AAV type 2.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301976

7 January 2021

Identification of the Arg-Gly-Asp sequence in laminin A chain as a latent cell-binding site being exposed in fragment P1

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301976

7 January 2021

Functional mimicry of protein A of Staphylococcus aureus by a proteolytically cleaved fragment

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301976

7 January 2021

Identifiers

DOI

10.1038/SJ.GT.3301976

1 reference

6 August 2017

1 reference